Zosano Pharma (ZSAN) Misses Q3 EPS by 2c

Zosano Pharma (NASDAQ: ZSAN) reported Q3 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18).

As of September 30, 2017, we had cash, cash equivalents and marketable securities of $19.8 million, debt of $8.2 million and 39.2 million common shares outstanding.

For earnings history and earnings-related data on Zosano Pharma (ZSAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Movano (MOVE) Misses Q2 EPS by 195c